These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 1350597)

  • 1. Potential arrhythmogenic role of cyclic adenosine monophosphate (AMP) and cytosolic calcium overload: implications for prophylactic effects of beta-blockers in myocardial infarction and proarrhythmic effects of phosphodiesterase inhibitors.
    Lubbe WF; Podzuweit T; Opie LH
    J Am Coll Cardiol; 1992 Jun; 19(7):1622-33. PubMed ID: 1350597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catecholamine-mediated arrhythmias in acute myocardial infarction. Experimental evidence and role of beta-adrenoceptor blockade.
    Opie LH; Lubbe WF
    S Afr Med J; 1979 Nov; 56(22):871-80. PubMed ID: 42151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of interventions that increase cyclic AMP levels on susceptibility to ventricular fibrillation in unanesthetized dogs.
    Avendano CE; Billman GE
    Eur J Pharmacol; 1994 Apr; 255(1-3):99-109. PubMed ID: 7517886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium antagonists, ventricular arrhythmias, and sudden cardiac death: a major challenge for the future.
    Opie LH
    J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S81-6. PubMed ID: 1725011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period.
    Hjalmarson A
    Am J Cardiol; 1997 Nov; 80(9B):35J-39J. PubMed ID: 9375948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy with beta-adrenergic receptor antagonists and phosphodiesterase inhibitors for chronic heart failure.
    Van Tassell BW; Radwanski P; Movsesian M; Munger MA
    Pharmacotherapy; 2008 Dec; 28(12):1523-30. PubMed ID: 19025433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of ventricular fibrillation, acute myocardial infarction (myocardial necrosis), heart failure, and mortality by bretylium: is ischemic heart disease primarily adrenergic cardiovascular disease?
    Bacaner M; Brietenbucher J; LaBree J
    Am J Ther; 2004; 11(5):366-411. PubMed ID: 15356432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined receptor intervention and myocardial infarction.
    Chamberlain DA; Vincent R
    Drugs; 1984; 28 Suppl 2():88-108. PubMed ID: 6151893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should calcium antagonists be used after myocardial infarction? Ischemia selectivity versus vascular selectivity.
    Opie LH
    Cardiovasc Drugs Ther; 1992 Feb; 6(1):19-24. PubMed ID: 1576093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine-sensitive ventricular tachycardia: evidence suggesting cyclic AMP-mediated triggered activity.
    Lerman BB; Belardinelli L; West GA; Berne RM; DiMarco JP
    Circulation; 1986 Aug; 74(2):270-80. PubMed ID: 3015453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postinfarction use of beta-blockers in elderly patients.
    Aronow WS
    Drugs Aging; 1997 Dec; 11(6):424-32. PubMed ID: 9413700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart rate changes preceding ventricular ectopy in patients with ventricular tachycardia caused by reentry, triggered activity, and automaticity.
    Stein KM; Karagounis LA; Markowitz SM; Anderson JL; Lerman BB
    Am Heart J; 1998 Sep; 136(3):425-34. PubMed ID: 9736133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium antagonists, ventricular fibrillation, and enzyme release in ischemic rat hearts.
    Opie LH; Thandroyen FT
    Fed Proc; 1983 May; 42(8):2465-9. PubMed ID: 6132839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of beta-blockers in preventing sudden death in heart failure.
    Teerlink JR; Massie BM
    J Card Fail; 2000 Jun; 6(2 Suppl 1):25-33. PubMed ID: 10908095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sympatho-adrenergic activation of the ischemic myocardium and its arrhythmogenic impact.
    Schömig A; Richardt G; Kurz T
    Herz; 1995 Jun; 20(3):169-86. PubMed ID: 7635399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential biochemical mechanisms for regulation of the slow inward current: theoretical basis for drug action.
    Lindemann JP; Bailey JC; Watanabe AM
    Am Heart J; 1982 Apr; 103(4 Pt 2):746-56. PubMed ID: 6121482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of beta-blockade on the incidence of ventricular tachyarrhythmias during acute myocardial ischemia: experimental findings and clinical implications.
    Haverkamp W; Gülker H; Hindricks G; Breithardt G
    Basic Res Cardiol; 1990; 85 Suppl 1():293-303. PubMed ID: 1982610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Renaissance of beta blocker therapy in myocardial infarct].
    Seidl K; Hauer B; Zahn R; Senges J
    Z Kardiol; 1996 Oct; 85(10):737-44. PubMed ID: 9036699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of verapamil and its isomers on vulnerability to ventricular fibrillation during acute myocardial ischemia and adrenergic stimulation in isolated rat heart.
    Thandroyen FJ; Higginson L; Opie LH
    J Mol Cell Cardiol; 1986 Jun; 18(6):645-9. PubMed ID: 2426459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contractile responses to selective phosphodiesterase inhibitors following chronic beta-adrenoreceptor activation.
    Osadchii OE; Woodiwiss AJ; Norton GR
    Pflugers Arch; 2006 May; 452(2):155-63. PubMed ID: 16369769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.